ArticleBMC musculoskeletal disorders2020

Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.

Esther Fernández-Simón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.